|
PD184161
|
5-溴-2-((2-氯-4-碘苯基)氨基)-N-(環(huán)丙基甲氧基)-3,4-二氟苯甲酰胺
|
212631-67-9
|
|
KEA1-97
|
KEA1-97
|
2138882-71-8
|
|
DI-591
|
DI-591
|
2245887-38-9
|
|
AP1867-3-(aminoethoxy)
|
AP1867-3-(Methoxyethylamine)
|
2127390-15-0
|
|
CA inhibitor 1
|
CA INHIBITOR 1
|
2189684-45-3
|
|
TL13-112
|
TL13-112
|
2229037-19-6
|
|
PKUMDL-LC-101-D04
|
PKUMDL-LC-101-D04
|
2143896-83-5
|
|
Eclitasertib
|
ECLITASERTIB
|
2125450-76-0
|
|
WM-3835
|
化合物WM-3835
|
2229025-70-9
|
|
BMS 753
|
4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid
|
215307-86-1
|
|
SMYD3-IN-1
|
SMYD3-IN-1
|
2095160-79-3
|
|
RAD51-IN-1
|
RAD51-IN-17
|
2101739-18-6
|
|
IACS-13909
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
|
Bocidelpar
|
化合物BOCIDELPAR
|
2095128-20-2
|
|
RORγt inverse agonist 13
|
化合物RORΓT INVERSE AGONIST 13
|
2170477-75-3
|
|
Enpatoran
|
化合物ENPATORAN
|
2101938-42-3
|
|
STING-IN-3
|
化合物C-171
|
2244881-69-2
|
|
LY392098
|
化合物 T27951
|
211311-39-6
|
|
Enpatoran hydrochloride
|
ENPATORAN HYDROCHLORIDE
|
2101945-93-9
|
|
Belotecan
|
羅漢松雙黃酮A
|
22136-74-9
|
|
Edaglitazone
|
依格列宗
|
213411-83-7
|
|
2'-O-Methylguanosine
|
2'-甲氧基鳥苷
|
2140-71-8
|
|
Raf inhibitor 2
|
220904-99-4
|
220904-99-4
|
|
LTβR-IN-1
|
Compound 919278
|
2189366-77-4
|
|
2BAct
|
2BAct(eIF2B activator 2BAct)
|
2143542-28-1
|
|
FLT3-IN-3
|
SAN50900
|
2229050-90-0
|
|
TP-021
|
BCL6 inhibitor 8c
|
2130878-25-8
|
|
BTK inhibitor 10
|
BTK inhibitor 10
|
2241732-30-7
|
|
MAGL-IN-4
|
His121 ARG57
|
2135785-20-3
|
|
GSK-3685032
|
GSK 3685032
|
2170137-61-6
|
|
Rimtuzalcap
|
化合物RIMTUZALCAP
|
2167246-24-2
|
|
FASN-IN-3
|
FASN inhibitor 1
|
2097262-60-5
|
|
JNJ4796
|
JNJ4796
|
2241664-16-2
|
|
EZH2-IN-2
|
EZH2-A€IN-A€2
|
2238821-31-1
|
|
Secnidazole-d
|
7-Benzofurancarboxylic acid, 6-fluoro-, ethyl ester
|
2114651-20-4
|
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
|
NHWD-870
|
化合物NHWD-870
|
2115742-03-3
|
|
Vociprotafib
|
RMC-4630
|
2172652-48-9
|
|
Vepafestinib
|
維利帕尼
|
2129515-96-2
|
|
Dynapyrazole-A
|
DYNAPYRAZOLE A
|
2226517-75-3
|
|
Aminopurvalanol A
|
AMINOPURVALANOL A
|
220792-57-4
|
|
α5IA
|
3-(5-甲基-3-異噁唑基)-6-[(1-甲基-1H-1,2,3-三氮唑-4-基)甲氧基][1,2,4]三氮唑并[3,4-A]酞嗪
|
215874-86-5
|
|
ZL0454
|
ZL0454
|
2229042-77-5
|
|
AP1867-2-(carboxymethoxy)
|
FKBP12 LIGAND
|
2230613-03-1
|
|
RIP1 kinase inhibitor 1
|
RIP1 KINASE INHIBITOR 1
|
2095515-38-9
|
|
Lisaftoclax
|
Bcl-2/Bcl-xl inhibitor 1
|
2180923-05-9
|
|
WEE1-IN-5
|
化合物DEBIO-0123
|
2243882-74-6
|
|
BMS-986299
|
BMS986299
|
2242952-69-6
|
|
MERS-CoV-IN-1
|
化合物MERS-COV-IN-1
|
2245697-92-9
|
|
Cyclic-di-GMP disodium
|
CYCLIC DI-GMP SODIUM
|
2222132-40-1
|
|
AOH1160
|
AOH1160
|
2089314-57-6
|
|
Diprovocim
|
Diprovocim
|
2170867-89-5
|
|
NCT-505
|
NCT-505
|
2231079-74-4
|
|
IDH1 Inhibitor 1
|
IDH1 INHIBITOR 1
|
2234285-81-3
|
|
JH-XI-10-02
|
JH-XI-10-02
|
2209085-22-1
|
|
PXS-5120A
|
PXS-5120A
|
2125955-70-4
|
|
VTP50469 fumarate
|
化合物 T13336L
|
2169919-29-1
|
|
Picroside IV
|
胡黃連苷IV
|
211567-04-3
|
|
XPC-6444
|
XPC-6444
|
2230144-21-3
|
|
SERCA2a activator 1
|
SERCA2a activator A
|
2139330-34-8
|
|
Alloxan hydrate
|
阿脲一水合物
|
2244-11-3
|
|
BC1618
|
化合物BC1618
|
2222094-18-8
|
|
Bemnifosbuvir hemisulfate
|
AT-527
|
2241337-84-6
|
|
Reuterin
|
羅氏菌素
|
2134-29-4
|
|
Gly-Phe-β-naphthylamide
|
(S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺
|
21438-66-4
|
|
ONO-4817
|
N-[(1S,3S)-1-[(ETHOXYMETHOXY)METHYL]-4-(HYDROXYAMINO)-3-METHYL-4-OXOBUTYL]-4-PHENOXYBENZAMIDE
|
223472-31-9
|
|
NCT-506
|
NCT-506
|
2231098-99-8
|
|
JNJ-55308942
|
JNJ-55308942
(JNJ55308942)
|
2166558-11-6
|
|
Inarigivir ammonium
|
INARIGIVIR銨
|
2172788-92-8
|
|
OBI-3424
|
OBI-3424
|
2097713-68-1
|
|
BMS-1166 hydrochloride
|
BMS-1166 HCl
|
2113650-05-6
|
|
AT-130
|
AT-130
(AT130)
|
211364-06-6
|
|
Londamocitinib
|
JAK1-IN-7
|
2241039-81-4
|
|
KDM2A/7A-IN-1
|
KDM2A/7A-IN-1
|
2169272-46-0
|
|
Safimaltib
|
1H-Pyrazole-4-carboxamide, 1-(1,2-dihydro-1-oxo-5-isoquinolinyl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)-4-pyridinyl]-
|
2230273-76-2
|
|
YTX-465
|
YTX-465
|
2225824-53-1
|
|
VB124
|
VB-124
|
2230186-18-0
|
|
EHMT2-IN-1
|
EHMT2-IN-1
|
2230849-55-3
|
|
Vebicorvir
|
ABI-H0731
|
2090064-66-5
|
|
CD73-IN-4
|
化合物CD73-IN-4
|
2216764-29-1
|
|
NV-5138
|
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)-
|
2095886-80-7
|
|
ENMD-1198
|
化合物 STAFIB-2
|
2097938-74-2
|
|
Dazcapistat
|
N-(4-AMINO-3,4-DIOXO-1-PHENYLBUTAN-2-YL)-4-(2-FLUOROPHENYL)-2-METHYLOXAZOLE-5-CARBOXAMIDE
|
2221010-42-8
|
|
Et-29
|
化合物ET-29
|
2166487-23-4
|
|
INCB086550
|
INCB084550
|
2230911-59-6
|
|
CDK12-IN-2
|
化合物CDK12-IN-2
|
2244987-03-7
|
|
SU0268
|
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]-
|
2210228-45-6
|
|
(Rac)-X77
|
化合物 CPD77
|
2144491-78-9
|
|
ZL0590
|
化合物ZL0590
|
2230496-99-6
|
|
Fanotaprim
|
化合物FANOTAPRIM
|
2120282-75-7
|
|
ML-211
|
化合物ML-211
|
2205032-89-7
|
|
TL13-12
|
TL13-12
|
2229037-04-9
|
|
TRPM8 antagonist 3
|
化合物TRPM8 ANTAGONIST 3
|
2102179-29-1
|
|
BIRT 377
|
BIRT 377
|
213211-10-0
|
|
FLT3-IN-10
|
化合物FLT3-IN-10
|
2088735-51-5
|
|
HeE1-2Tyr
|
化合物HEE1-2TYR
|
2245195-67-7
|
|
MS4077
|
MS4077
|
2230077-10-6
|
|
ELOVL1-IN-1
|
化合物ELOVL1-IN-1
|
2227482-41-7
|
|
MLT-747
|
MLT-747
|
2097853-86-4
|
|
CMPD-39
|
化合物USP30 INHIBITOR 18
|
2242582-40-5
|